Radiotherapy plays a central part in curing cancer. For decades, most research on improving
treatment outcomes has focused on modulating radiation-induced biological effects on …

The development of immune checkpoint inhibitors (ICIs) is revolutionizing the way we think
about cancer treatment. Even so, for most types of cancer, only a minority of patients currently …

Imaging of collectively invading cocultures of carcinoma cells and stromal fibroblasts reveals
that the leading cell is always a fibroblast and that carcinoma cells move within tracks in the …

Purpose: To conduct a phase I clinical trial with a second-generation oncolytic herpes simplex
virus (HSV) expressing granulocyte macrophage colony-stimulating factor (Onco VEX GM-…

Background There are few effective treatment options for patients with recurrent or metastatic
head-and-neck squamous cell carcinoma. Pembrolizumab showed antitumour activity and …

Background Patients with recurrent or metastatic squamous-cell carcinoma of the head and
neck after platinum chemotherapy have a very poor prognosis and limited therapeutic …

Talimogene laherparepvec (T-VEC) is a herpes simplex virus type 1-derived oncolytic
immunotherapy designed to selectively replicate within tumors and produce granulocyte …

Background Pembrolizumab is active in head and neck squamous cell carcinoma (HNSCC),
with programmed cell death ligand 1 (PD-L1) expression associated with improved …

Background Xerostomia is the most common late side-effect of radiotherapy to the head and
neck. Compared with conventional radiotherapy, intensity-modulated radiotherapy (IMRT) …

To learn more about cancer-associated fibroblasts (CAFs), we have isolated fibroblasts from
different stages of breast cancer progression and analysed their function and gene …